Healthcare and Biotech Sector

Company: CannaRoyalty Corp. Symbol: CSE: CRZ Length: 00:21:53 Presenter: Afzal Hasan, Executive VP Corporate Development Occasion: Richmond Club Lunch, Toronto CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is to build and support a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including …

Canna Royalty – Diversified Portfolio in High-Value Segments of Cannabis Sector Read More »

Company: Aphria Inc Symbol: CVE: APH Length: 00:24:03 Presenter: Vic Neufeld, Chairman Occasion: Richmond Club Lunch, Toronto Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the “Marihuana for Medical Purposes Regulations” (the “MMPR”). Under …

Aphria – Developing the Medical Marijuana Business Read More »

Company: Oncolytics Biotech Inc. Symbol: TSX: ONC Length: 00:19:39 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in late stage …

Oncolytics Biotech – Development of Oncolytic Viruses Read More »

Company: DelMar Pharmaceuticals, Inc Symbol: NASDAQ: DMPI Length: 00:26:11 Presenter: Jeffrey Bacha, Chairman Occasion: Richmond Club Lunch, Toronto DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. Product Information The Company’s lead asset, VAL-083, is currently undergoing …

DelMar Pharmaceuticals Develops and Commercializes Proven Cancer Therapies Read More »

Company: VolitionRx Ltd. Symbol: NYSE MKT: VNRX Length: 00:23:42 Presenter: Cameron Reynolds, President and CEO Occasion: Richmond Club Lunch, Toronto VolitionRx’s mission is to address the need for non-invasive, accurate, and cost-effective diagnostics for cancer and other conditions, with our NuQ® suite of products. About VolitionRx VolitionRx was established in 2010, when our team of …

VolitionRx Addresses Need for Cancer Diagnostics Read More »

Company: Aphria Inc Symbol: CVE: APH Length: 00:37:21 Presenter: Vic Neufeld, Chairman Occasion: Richmond Club Lunch, Toronto Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the “Marihuana for Medical Purposes Regulations” (the “MMPR”). Under …

Aphria Focusses on Medical Marijuana Business Read More »

Company: Pressure BioSciences, Inc Symbol: OTCQB: PBIO Length: 00:25:37 Presenter: Richard T. Schumacher, President ,CEO & Founder Occasion: Richmond Club Lunch, Toronto We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology (“PCT”). PCT uses cycles of hydrostatic pressure between ambient and ultra-high …

Pressure BioSciences Well Positioned to Take Advantage of Cancer Moonshot Read More »

Company: Resverlogix Corp. Symbol: TSX: RVX Length: 00:20:29 Presenter: Donald J. McCaffrey, President and CEO Occasion: Richmond Club Lunch, Toronto Resverlogix Corp. (TSX: RVX) is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. Resverlogix is developing RVX-208, a first-in-class small molecule for the treatment of atherosclerosis. RVX-208 is the …

Resverlogix Modulates Protein Production with Epigenetic Platform Technology Read More »

Company: Oncolytics Biotech Inc. Symbol: TSX: ONC, OTCQX: ONCYF Length: 00:23:53 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in …

Oncolytics Biotech Focused on Oncolytic Viruses for Cancer Therapeutics Read More »

Company: MedX Health Corp Symbol: Private Length: 00:17:28 Presenter: Rob von der Porten, President & CEO Occasion: Richmond Club Lunch, Toronto MedX is a 12 year old Canadian company that is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technologies for use in numerous medical settings, …

MedX a Global Leader in Low Level Laser and Light Therapy Technologies Read More »

{"cart_token":"","hash":"","cart_data":""}